Litcius/Paper detail

Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels

Jiang Lv, Le Qin, Ruocong Zhao, Di Wu, Zhiping Wu, Diwei Zheng, Siyu Li, Mintao Luo, Qiting Wu, Youguo Long, Zhaoyang Tang, Yan‐Lai Tang, Xue‐Qun Luo, Yao Yao, Li-Hua Yang, Peng Li

2022Molecular Therapy — Oncolytics39 citationsDOIOpen Access PDF

Abstract

. The level of FBXO38, a ubiquitination-regulating protein that reduces PD-1 expression, was elevated in activated T cells after CISH ablation. Hence, this study reveals a mechanism by which CISH promotes PD-1 expression by suppressing the expression of FBXO38 and proposes a new strategy for augmenting the therapeutic effect of CAR-T cells by inhibiting CISH.

Topics & Concepts

CISHCytokineCancer researchImmune systemT cellChimeric antigen receptorCell biologyBiologyChemistryImmunologyBiochemistryGene expressionGeneIn situ hybridizationCAR-T cell therapy researchImmune Cell Function and InteractionCancer Immunotherapy and Biomarkers
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels | Litcius